Nitric oxide synthases, cyclooxygenase-2, nitrotyrosine, and angiogenesis in chondrosarcoma and their relation to prognosis.
BACKGROUND
The localization in tumor tissue of various markers by immunohistochemistry can help to establish a diagnosis or predict prognosis. Nitric oxide is associated with tumors and has been studied indirectly by nitrotyrosine analysis and with use of the enzymes nitric oxide synthase (NOS)1, NOS2, and NOS3. Nitric oxide reacts with superoxide anions to yield peroxynitrite, which has toxic effects on genes. Peroxynitrite adds a nitro group to the benzene ring of tyrosine to form nitrotyrosine. The accumulation of nitrotyrosine, a stable product in cells, indicates the formation of peroxynitrite. Nitric oxide stimulates the production of cyclooxygenase-2 (COX-2), which has been associated with angiogenesis in tumors. Neovascularization influences tumor prognosis, as demonstrated by microvessel studies with use of CD34, an immunohistochemical endothelial cell marker. This study examines the expression of these markers in chondrosarcomas and their relation to histological grade and prognosis.


METHODS
Tissue microarrays composed of formalin-fixed tissue samples from 101 patients with chondrosarcoma were immunohistochemically stained to localize NOS1, NOS2, NOS3, COX-2, nitrotyrosine, and CD34. Five samples of normal cartilage were used as controls. Patient demographics, selected surgical variables, and tumor grade were tabulated, and the associations were analyzed. Analyses of local and overall survival rates were performed with use of the Kaplan-Meier method, and multivariable analyses were performed.


RESULTS
There was a significant association of nitrotyrosine, COX-2, and CD34 with histological grades (p = 0.022, p = 0.014, and p = 0.028, respectively), but not with overall prognosis (p = 0.064, p = 0.143, and p = 0.581, respectively). The presence of NOS2 was associated with a lower rate of local disease-free survival (p = 0.038), and positive expressions of NOS1 and NOS2 were associated with decreased overall survival rates (p = 0.007 and p < 0.001, respectively). On multivariable analysis, NOS2 expression demonstrated an independent prognostic impact on local disease-free survival; NOS1 and NOS2 expression was a dependent variable, and their isolated or combined expression was related to lower overall survival rates (p = 0.046 and p = 0.004) (hazard ratio, 3.17 [95% confidence interval, 1.0 to 9.8] and 5.58 [95% confidence interval, 1.7 to 18.0], respectively).


CONCLUSIONS
Immunohistochemical markers may have an independent value in predicting the prognosis for patients with chondrosarcoma.
Nakagawa
Suely Akiko
SA
Departamentos de Cirurgia Pélvica-Ortopedia, Hospital A.C. Camargo, Rua Prof. Antonio Prudente, 211, São Paulo - S. P., CEP 01509-010, Brazil. su@uol.com.br
Lopes
Ademar
A
Lopes de Carvalho
André
A
Rossi
Benedito Mauro
BM
Werneck da Cunha
Isabela
I
Soares
Fernando Augusto
FA
Chung
Wu Tu
WT
Alves
Lucíola Assunção
LA
D018952:Antigens, CD34 / Q000096:biosynthesis; D014408:Biomarkers, Tumor / Q000096:biosynthesis; D001859:Bone Neoplasms / Q000378:metabolism* / Q000401:mortality / Q000473:pathology; D002813:Chondrosarcoma / Q000378:metabolism* / Q000401:mortality / Q000473:pathology; D051546:Cyclooxygenase 2 / Q000096:biosynthesis*; D006801:Humans; D007150:Immunohistochemistry; D009367:Neoplasm Staging; D009389:Neovascularization, Pathologic / Q000378:metabolism*; D019001:Nitric Oxide Synthase / Q000096:biosynthesis*; D011237:Predictive Value of Tests; D011379:Prognosis; D016019:Survival Analysis; D014443:Tyrosine / Q000031:analogs & derivatives* / Q000096:biosynthesis
D018952:Antigens, CD34; D014408:Biomarkers, Tumor; C002744:3-nitrotyrosine; D014443:Tyrosine; D019001:Nitric Oxide Synthase; D051546:Cyclooxygenase 2